According to Global Market Insights, Inc., “Medical Polymers Market size will exceed USD 24 billion by 2024 gaining the industry by CAGR close to 9%.” The healthcare sector has observed a paradigm shift since the last few years, subject to which Medical Polymers Market will depict a lucrative growth path.
Of late, there has been a spur in the prevalence of chronic ailments such as cardiovascular disorders, infections, hypertension, dementia, osteoporosis, and arthritis, thereby boosting global pharmaceutical and healthcare sectors, which are key drivers propelling medical polymers market.
The ever-growing geriatric population across the globe and the rising awareness regarding efficient medical devices and equipment will also fuel medical polymers industry, set to cross a valuation of USD 24 billion by 2024, with a CAGR estimation of 9% over 2016-2024.
To access a sample copy or view the Medical Polymers Market report in detail along with the table of contents, please click the link below: https://www.gminsights.com/request-sample/detail/1126
Companies operating in global medical polymers market adopt varied business strategies such as collaborations, R&D investments, and mergers & acquisitions to sustain their position. This industry is highly fragmented and involves the partaking of myriad local medium and large-sized businesses. Major players operating in medical polymers market include Evonik Industries, DuPont, Huntsman, Bayer AG, Dow Chemicals, Celanese Corporation, and Eastman Chemicals. Medical polymers market firms constantly strive to upgrade their product portfolio and improve their service sphere to score an edge over competitors.
Global pharmaceutical device market was valued over USD 300 billion in 2015 and is anticipated to register a notable CAGR of more than 6% over the next seven years. U.S. held more than 45% of this share in 2015, subject to which pharmaceutical device industry from the U.S. is estimated to grow remarkably over the next few years. This will significantly propel U.S. medical polymers market as well.
More than 20% of the population in the United States is likely to be above 65 years of age by 2030, and is expected to be susceptible to chronic ailments. Thus, the rapidly growing elderly population will fuel U.S. medical polymers market over 2016-2024. North America medical polymers industry was valued over USD 4.5 billion in 2015, and will grow noticeably over the years ahead, driven by the rapidly developing medical & pharma sectors, increasing healthcare spending, and public awareness related to health issues. Additionally, this region will witness huge product application in medical packaging and medical devices & equipment sectors, which will fuel North America medical polymers market.
Medical polymers industry from medical packaging applications will register a notable growth rate over the next seven years, subject to the production of biodegradable and bio-based polymers for packing medical products and disposables. In addition, the government as well as leading medical organizations have introduced legislations pertaining to the medical disposables and the usage of polymers for packaging, which will propel medical polymers market from medical packaging applications, set to grow at a rate of 9% over 2016-2024.
Medical devices and equipment on the other hand, accounted for more than 50% of the overall medical polymers industry in 2015. Pertaining to the properties of zero chemical corrosion and ease of application, medical polymers market from medical devices & equipment will grow at a CAGR of 8% over 2016-2024.